Skip to Content
View site list


Pre-Bid Projects

Pre-Bid Projects

Click here to see Canada’s most comprehensive listing of projects in conceptual and planning stages


Corealis Pharma doubles size of Laval plant

Corealis Pharma doubles size of Laval plant

LAVAL, QUE. — Corealis Pharma has announced completion of a project to expand its plant in Biotech City in Laval, Que.

The $10 million expansion increased the premises of the Quebec-based company from 33,000 to 63,000 square feet, enabling the installation of new laboratories, stated a release.

The firm is active in the Contract Research and Development Organizations (CRO/CDMO) sector with clientele predominantly located in New England and California.

“Corealis elevates the profile of Quebec and the city of Laval, in particular,” stated Laval City coun. Christine Poirier in a statement. “We take immense pride in supporting the directors and employees of this esteemed company, facilitating its continued growth on our soil, thus reaffirming Biotech City as a premier destination for investment and advancement in Quebec’s life sciences landscape.”

Recent Comments

Your comment will appear after review by the site.

You might also like